Mary Harner

Mary Harner possesses extensive experience in the pharmaceutical industry, currently serving as WW Medical Lead for Oncology Early Assets at Bristol Myers Squibb since August 2014, with a progression through various roles including Associate Director and Senior Research Investigator. Expertise includes biophysical methods for detecting small molecule binding and mechanistic binding studies, utilizing techniques such as NMR, thermal shift assays, and SPR. Additionally, Mary teaches group fitness classes with a focus on high-intensity interval training and Spinning, contributing to fitness organizations like Team85 Fitness & Wellness and RWJ Fitness & Wellness Center. Academic credentials include a PhD in Pharmaceutical Sciences from the University of North Carolina at Chapel Hill and a BS in Biochemistry from Elizabethtown College.